SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 52 filers reported holding SCPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $569 | -65.3% | 55,886 | -69.1% | 0.00% | -50.0% |
| Q1 2023 | $1,642 | +9.0% | 180,986 | -13.8% | 0.00% | 0.0% |
| Q4 2022 | $1,506 | -99.9% | 209,986 | +16.5% | 0.00% | 0.0% |
| Q3 2022 | $1,175,000 | +27.3% | 180,286 | -5.9% | 0.00% | +100.0% |
| Q2 2022 | $923,000 | -12.7% | 191,586 | +3.0% | 0.00% | 0.0% |
| Q1 2022 | $1,057,000 | +11.4% | 186,086 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $949,000 | -26.3% | 188,986 | -2.4% | 0.00% | -50.0% |
| Q3 2021 | $1,287,000 | -2.7% | 193,586 | -10.6% | 0.00% | 0.0% |
| Q2 2021 | $1,323,000 | +3.9% | 216,486 | +13.1% | 0.00% | 0.0% |
| Q1 2021 | $1,273,000 | -2.6% | 191,386 | -22.5% | 0.00% | +100.0% |
| Q4 2020 | $1,307,000 | -41.2% | 247,086 | -17.1% | 0.00% | -50.0% |
| Q3 2020 | $2,221,000 | -9.6% | 298,079 | -10.7% | 0.00% | 0.0% |
| Q2 2020 | $2,456,000 | +72.5% | 333,686 | +73.4% | 0.00% | +100.0% |
| Q1 2020 | $1,424,000 | +53.8% | 192,486 | +17.6% | 0.00% | 0.0% |
| Q4 2019 | $926,000 | +40.7% | 163,677 | +46.0% | 0.00% | 0.0% |
| Q3 2019 | $658,000 | +353.8% | 112,131 | +146.4% | 0.00% | – |
| Q2 2019 | $145,000 | – | 45,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,051,805 | $20,907,893 | 8.53% |
| 5AM Venture Management, LLC | 1,200,647 | $12,234,593 | 3.05% |
| Worth Venture Partners, LLC | 512,337 | $5,220,714 | 2.84% |
| COWEN AND COMPANY, LLC | 1,837,918 | $18,728,384 | 1.55% |
| Orbimed Advisors | 5,559,528 | $56,651,590 | 1.03% |
| RTW INVESTMENTS, LP | 3,297,843 | $33,605,020 | 0.64% |
| EAM Investors, LLC | 265,528 | $2,705,730 | 0.50% |
| Rubric Capital Management LP | 811,517 | $8,269,358 | 0.35% |
| Ikarian Capital, LLC | 150,000 | $1,528,500 | 0.24% |
| Leucadia National | 831,000 | $8,467,890 | 0.08% |